These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 33682961)
1. Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer. Xia J; Luo M; Dai L; Wang L; Wang L; Zhu J J Clin Lab Anal; 2021 May; 35(5):e23743. PubMed ID: 33682961 [TBL] [Abstract][Full Text] [Related]
2. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728 [TBL] [Abstract][Full Text] [Related]
3. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
4. The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients. Szpechcinski A; Florczuk M; Duk K; Zdral A; Rudzinski S; Bryl M; Czyzewicz G; Rudzinski P; Kupis W; Wojda E; Giedronowicz D; Langfort R; Barinow-Wojewodzki A; Orlowski T; Chorostowska-Wynimko J Cell Mol Life Sci; 2019 Sep; 76(18):3641-3656. PubMed ID: 30953094 [TBL] [Abstract][Full Text] [Related]
5. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918 [No Abstract] [Full Text] [Related]
7. Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients. Janpipatkul K; Trachu N; Watcharenwong P; Panvongsa W; Worakitchanon W; Metheetrairut C; Oranratnachai S; Reungwetwattana T; Chairoungdua A Cancer Biomark; 2021; 31(3):281-294. PubMed ID: 33896827 [TBL] [Abstract][Full Text] [Related]
9. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients. Zhang Y; Zhang Y; Yin Y; Li S Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974 [TBL] [Abstract][Full Text] [Related]
10. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma. Xue X; Wang C; Xue Z; Wen J; Han J; Ma X; Zang X; Deng H; Guo R; Asuquo IP; Qin C; Wang H; Gao Q; Liu S; Wang J Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):281-293. PubMed ID: 32073597 [TBL] [Abstract][Full Text] [Related]
11. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer. Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472 [TBL] [Abstract][Full Text] [Related]
12. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252 [TBL] [Abstract][Full Text] [Related]
13. Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation. Wang S; Su X; Bai H; Zhao J; Duan J; An T; Zhuo M; Wang Z; Wu M; Li Z; Zhu J; Wang J J Hematol Oncol; 2015 Nov; 8():127. PubMed ID: 26563758 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy. Yuwen D; Ma Y; Wang D; Gao J; Li X; Xue W; Fan M; Xu Q; Shen Y; Shu Y Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):163-173. PubMed ID: 30228154 [TBL] [Abstract][Full Text] [Related]
15. Dynamic Evaluation of Circulating miRNA Profile in Leonetti A; Capula M; Minari R; Mazzaschi G; Gregori A; El Hassouni B; Papini F; Bordi P; Verzè M; Avan A; Tiseo M; Giovannetti E Cells; 2021 Jun; 10(6):. PubMed ID: 34208765 [TBL] [Abstract][Full Text] [Related]
16. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway. Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108 [TBL] [Abstract][Full Text] [Related]
18. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer. Dong X; Chang M; Song X; Ding S; Xie L; Song X Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399 [TBL] [Abstract][Full Text] [Related]
19. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis. Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822 [TBL] [Abstract][Full Text] [Related]
20. Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer. Zhang ZJ; Song XG; Xie L; Wang KY; Tang YY; Yu M; Feng XD; Song XR Exp Biol Med (Maywood); 2020 Oct; 245(16):1428-1436. PubMed ID: 32741216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]